RxDoctor Payments Data

Richard Barrett, MD

Internal Medicine · Savannah, GANPI 1538194634

Payments from drug & device makers

$783in general payments, 2019–2025

Across 48 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$239
  • Amgen$114
  • AbbVie$83
  • Abbott$63
  • Johnson & Johnson$59
  • Pfizer$43
  • plus $181 from 10 others

What the payments were for

  • Food & beverage$76898%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$783 in reported general payments places this provider in the 60th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$28,439
Medicare patients
215
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$76,552
TrulicityDulaglutide52$59,205
Repatha SureclickEvolocumab63$57,887
EliquisApixaban56$49,830
JardianceEmpagliflozin32$39,851
JanuviaSitagliptin Phosphate28$28,635
MounjaroTirzepatide15$18,580
XareltoRivaroxaban16$16,041
Praluent PenAlirocumab19$13,256
FarxigaDapagliflozin Propanediol11$9,573
Tresiba Flextouch U-100Insulin Degludec21$8,308
Levothyroxine Sodium319$3,709
Atorvastatin Calcium389$3,323
Losartan Potassium249$3,186
Rosuvastatin Calcium201$2,441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$15$77,78567 claims
Novo NordiskOzempic$239$76,55271 claims
PfizerEliquis$43$49,83056 claims
MerckJanuvia$12$28,63528 claims
Johnson & JohnsonXarelto$59$16,04116 claims
AbbVieSynthroid$83$91620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →